Previous Page  28 / 28
Information
Show Menu
Previous Page 28 / 28
Page Background

Page 63

conferenceseries

.com

Volume 08

Journal of Alzheimers Disease & Parkinsonism

Alzheimer's Congress 2018

May 30-31, 2018

May 30-31, 2018 Osaka, Japan

10

th

World Congress on

Alzheimer's Disease & Dementia

J Alzheimers Dis Parkinsonism 2018, Volume 8

DOI: 10.4172/2161-0460-C4-046

Orthosiphon stamineus improves cognitive functions after ICV streptozotocin insult in alzheimer’s

disease model

Thaarvena Retinasamy

Monash University Malaysia Campus, Malaysia

A

lzheimer’s disease is a chronic neurodegenerative disease that causes cognitive impairment like learning and memory.

Orthosiphon stamineus

(OS) is a medicinal herb that has been reported to exert various pharmacological activities. The

objective of this study was to evaluate whether this Malaysian plant extract can reverse Streptozotocin (STZ) induced cognitive

dysfunction in experimental animals. Rats were subjected to Intra Cerebro Ventricular (ICV) injections of STZ (3 mg/kg)

bilaterally. The STZ-injected rats received oral treatment of OS (50,100 and 200 mg/kg) one day after the surgery, for 7 days

before being subjected to behavioral analysis. The learning and memory performance was assessed using passive avoidance and

elevated plus maze tests. It was found that the OS administration significantly attenuated learning and memory impairment

induced by STZ-injection. The hippocampal tissues were extracted for gene expression analysis, known to be modulated in AD

condition. All the three doses demonstrated effectiveness against Scopolamine-induced cognitive impairment when compared

to the negative control group. Therefore, these results demonstrate the effectiveness of OS in averting cognitive deficits could

serve as a potential therapeutic option for the treatment of neurodegenerative diseases like AD.

thaarvena@gmail.com